Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Heron Therapeutics Inc (HRTX) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Trading halt imposed on Bighorn Metals Corp. shares by Canadian regulator CIRO.

The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...

Market News
1 hour ago
Globe Newswire
Neutral
Trading halt imposed on Bighorn Metals Corp. shares by Canadian regulator CIRO.

FDA approves Jemperli as first immunotherapy for advanced MSI-H/dMMR rectal cancer, avoiding chemo and surgery.

The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...

Market News
1 hour ago
Anaptysbio, Inc.
Bullish
news icon
FDA approves Jemperli as first immunotherapy for advanced MSI-H/dMMR rectal cancer, avoiding chemo and surgery.

Ethereum-based crypto Pepeto nears Binance listing as Cardano eyes 6x price rise by 2026

Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...

Market News
2 hours ago
Not Specified
Bullish
news icon
Ethereum-based crypto Pepeto nears Binance listing as Cardano eyes 6x price rise by 2026

Migraine market to grow 6% by 2036 with new therapies beyond CGRP targeting PACAP and TRPA1.

The global migraine market is projected to expand at a 6% annual growth rate through 2036, driven by rising migraine prevalence, better diagnosis, and awareness. Innovative treatments beyond traditional CGRP inhibitors, including PACAP-targeted thera...

Market News
3 hours ago
Delveinsight
Bullish
news icon
Migraine market to grow 6% by 2036 with new therapies beyond CGRP targeting PACAP and TRPA1.

Signet Jewelers insider sold $240K in shares under prearranged plan amid stable stock metrics

A Signet Jewelers officer sold 2,000 shares worth $240,000 in mid-October under a prearranged Rule 10b5-1 trading plan, which allows scheduled insider trades. The sales reduced the officer's holdings by about 1.94%. Signet's stock opened at $118.18 w...

Market News
4 hours ago
Andrew Wynn
Neutral
Signet Jewelers insider sold $240K in shares under prearranged plan amid stable stock metrics

Palantir's TITAN contract signals shift to operational AI in defense, boosting recurring cash flow despite high valuation.

Palantir Technologies' recent TITAN system delivery contract highlights its strategic role in the growing U.S. and global defense sector. This contract marks a transition from AI concept to practical use, providing Palantir with a steady, high-margin...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Palantir's TITAN contract signals shift to operational AI in defense, boosting recurring cash flow despite high valuation.

Bank OZK raises dividend to 4.3% yield amid risks from its large construction loan portfolio.

Bank OZK has increased its quarterly dividend to $0.49 per share, yielding 4.31%, continuing a streak of raises since 2019. The bank's earnings cover the dividend comfortably, with a payout ratio of about one-third, allowing room for growth. However,...

Market News
4 hours ago
24/7 Wall Street
Neutral
Bank OZK raises dividend to 4.3% yield amid risks from its large construction loan portfolio.

Treasury yields rise again as borrowing costs climb, attracting investors back to bonds.

Treasury bond yields, including the 10-year note, have risen again after a recent sharp decline, with the 10-year yield reaching 5.31% before settling at 5.14%. This increase in yields means borrowing costs are higher, which has started to attract in...

Market News
4 hours ago
Market Watch
Neutral
Treasury yields rise again as borrowing costs climb, attracting investors back to bonds.

Vanguard FTSE Europe ETF expected to drop 7-14% amid European stagflation concerns

The Vanguard FTSE Europe ETF (VGK) is predicted to decline by 7-14% due to expected stagflation in Europe, characterized by rising inflation and weak economic growth. The current risk premium and earnings yield of VGK are considered insufficient to o...

Market News
4 hours ago
Seeking Alpha
Bearish
news icon
Vanguard FTSE Europe ETF expected to drop 7-14% amid European stagflation concerns

GoldCoast confirms its offshore licences in Ghana remain valid despite false suspension claims.

GoldCoast Resource Corp. clarified that its offshore licences in Ghana have not been suspended, contradicting a letter from the Office of the Secretary to the President that was sent to the National Fisheries Association of Ghana. The company confirm...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
GoldCoast confirms its offshore licences in Ghana remain valid despite false suspension claims.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $69.22M
  • Volume
    1,735,819
  • Sector
    Health
  • 52W High
    $1.49
  • 52W Low
    $0.27
  • Typical Hold Time
    37 Days
  • Enterprise Value
    $175.96M
  • Div Yield
    -
  • Trading Activity
    42% Sell | 58% Buy
$0.36
52W Low: $0.27
21 Sep 2026
52W High: $1.49
16 Jan 2026

Track Heron Therapeutics Inc (HRTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Heron Therapeutics Inc has traded between a low of $0.27 and a high of $1.49, highlighting its annual price range. Buy and sell Heron Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!